SNF1 protein kinase; angiotensin II; transforming growth factor-␤; renal epithelial cell PROTEIN KINASES ARE a key component of many signaling pathways in eukaryotic cells, and the accumulated evidence shows them to be important regulators of such cell activities as proliferation, differentiation, and development. We previously performed a screen to identify protein kinases that were expressed in the early differential stage of mouse embryonic stem cells (ES cells), by using degenerative oligonucleotide primers specific to consensus sequences of a number of protein kinase domains (7). In this paper, we focused our studies on one positive clone with a predicted putative kinase domain structure, since sequence analysis revealed that this clone was a partial cDNA encoding hormonally upregulated Neu-associated kinase (MAK-V/Hunk) that was originally cloned by Gardner et al. (6) and Korobko et al. (18).
PROTEIN KINASES ARE a key component of many signaling pathways in eukaryotic cells, and the accumulated evidence shows them to be important regulators of such cell activities as proliferation, differentiation, and development. We previously performed a screen to identify protein kinases that were expressed in the early differential stage of mouse embryonic stem cells (ES cells), by using degenerative oligonucleotide primers specific to consensus sequences of a number of protein kinase domains (7) . In this paper, we focused our studies on one positive clone with a predicted putative kinase domain structure, since sequence analysis revealed that this clone was a partial cDNA encoding hormonally upregulated Neu-associated kinase (MAK-V/Hunk) that was originally cloned by Gardner et al. (6) and Korobko et al. (18) .
The MAK-V/Hunk protein has an NH 2 -terminal (N-terminal) catalytic domain typical of serine/threonine kinases and an SNF1-homology domain immediately after this catalytic domain. The protein also has a unique COOH-terminal (Cterminal) part without homology to any known protein. SNF1 family members have been implicated in the regulation of developmental processes including cell cycle control, the establishment of cell polarity, and differentiation. For example, the MARK/Par-1 subgroup of the SNF-1-like protein has been shown to be involved in the establishment of anterior-posterior polarity in early embryonic development as well as the maintenance of epithelial cell polarity (11) , and SNF-1 itself has been found to mediate cell-cycle arrest in response to starvation (30) . In fact, the MAK-V/Hunk mRNA of Xenopus laevis is predominantly found on the animal hemisphere of the egg (22) . Although MAK-V/Hunk mRNA has been reported to be expressed in a variety of tissues of the adult mouse, such as the ovary, thymus, lung, brain, breast, uterus, liver, and kidney in vivo (6) , no specific cellular targets or specific sequences of molecular events involving MAK-V/Hunk in vitro have been identified to date. In the present study, we developed a polyclonal anti-MAK-V/Hunk antibody and focused our investigation on the renal distribution/localization and developmental expression of MAK-V/Hunk in vivo and the renal cellular function in vitro. In the course of these studies, we demonstrated that MAK-V/Hunk is abundantly expressed in the kidney with localization to the renal distal tubules in vivo and that MAK-V/Hunk is specifically involved in the inhibition of ANG II-induced proliferative responses of renal distal tubular cells.
MATERIALS AND METHODS
Materials. ANG II, endothelin-1, and aldosterone were purchased from Sigma. The AT 1 receptor-specific antagonist telmisartan and AT2 receptor-specific antagonist PD123319 were supplied by Boehringer Ingelheim and Parke Davis, respectively.
Plasmid construction. We subcloned MAK-V/Hunk cDNA in pcDNA3.1(ϩ) (Invitrogen) and pSRK-HA (kindly provided by Dr. S Ohno, Department of Molecular Biology, Yokohama City University) to produce expression vectors for MAK-V/Hunk (pc-MAK-V/Hunk) and NH 2-terminal HA-tagged MAK-V/Hunk (pHA-MAK-V/Hunk), respectively.
Cell culture. H9c2 cells were cultured as described previously (28) . Mouse distal convoluted tubule cells (mDCT cells) were kindly provided by Dr. P. A. Friedman (University of Pittsburgh School of Medicine, Pittsburgh, PA). The cells had been previously isolated and functionally characterized as described previously (8 -10, 20) . Cells were grown on 100-mm dishes (Corning) in DMEM/HAM F-12 media (1:1; Sigma) supplemented with 5% heat-inactivated fetal calf serum (MBL), 2 mM L-glutamine (GIBCO), 0.5 g/ml streptomycin, 0.5 g/ml penicillin, and 1 g/ml neomycin (GIBCO), in a humidified atmosphere of 5% CO 2-95% air at 37°C.
Animals. Adult male C57BL/6J (8 -12 wk), housed under a 12:12-h day-night cycle at a temperature of 25°C and given free access to tap water and fed a standard pellet diet, were used for the present study. For the salt depletion study, 8-wk-old mice were placed on a low-salt (0.02% NaCl, n ϭ 4) or a normal-salt (0.3% NaCl, n ϭ 4) diet for 2 wk, as described previously (31) . Systolic blood pressure was measured by the tail cuff method (BP-monitor MK-2000; Muromachi Kikai). Following experimental treatment, the mice were anesthetized and the tissues were removed and placed into liquid nitrogen or fixative. The experimental protocols were approved by the Yokohama City University School of Medicine Institutional Care and Use Committee.
RNA isolation and Northern blot analysis. Total RNA was isolated from snap-frozen tissue samples and cultured cells, using single-step method with acid guanidinium thiocyanate-phenol-chloroform extraction. Total RNA (30 g) was size fractionated on agarose gels and transferred to nylon membranes (Amersham). The membranes were hybridized with 32 P-labeled probes, corresponding to amino acid residues 182-249 of MAK-V/Hunk and 18S ribosomal RNA, respectively. The membrane was then washed and exposed to the imaging plate of FUJIX BIO-Imaging Analyzer BAS2500 (Fuji Photo Film) as described previously (26, 27) .
RT-PCR analysis. RT-PCR was performed to examine the endogenous expression of MAK-V/Hunk mRNA in the renal cortex and medulla, essentially as described previously (28) . Briefly, aliquots of total RNA (3 g) were reverse-transcribed into cDNA with 50 U/ml reverse transcriptase (Superscript, Invitrogen) at 37°C for 1 h in standard buffer. For the amplification of MAK-V/Hunk cDNA, the following oligonucleotide primers were designed: sense primer 5Ј-GGAGAGGGCTCCTTCGCCAAG-3Ј; antisense primer 5Ј-GGGGC-CATATTTCTTCCTGGCAAGC-3Ј, which amplify 521 bp of the MAK-V/Hunk cDNA (6) . The amplification protocol consisted of 35 cycles of denaturation at 95°C for 15 s and annealing at 60°C for 60 s. The reaction was carried out in a standard reaction mixture and PCR products were analyzed on a 1.0% agarose gel.
Real-time quantitative RT-PCR was also performed to examine the effect of salt depletion on MAK-V/Hunk and AT1 receptor mRNA expression in the mouse kidney, as described previously (13) . Briefly, PCR was performed by incubating the RT product with the TaqMan Universal PCR Master Mix and designed TaqMan probe (Applied Biosystems). Wells were sealed with an optical sheet, and the PCR reaction was run on an ABI prism 7700 using standard conditions. Expression levels of MAK-V/Hunk and AT1 receptor mRNA were normalized with 18S ribosomal RNA levels.
Production of rabbit anti-MAK-V/Hunk antibody. A 16-aa synthetic peptide corresponding to amino acid residues 44 -59 of the MAK-V/Hunk protein was produced using standard solid-phase peptide synthesis techniques. Analysis using the BLAST computer program showed no significant overlap of the immunizing peptide with any known eukaryotic protein. The peptide was purified, conjugated, and injected three times intradermally into rabbits at 2-wk intervals for the production of polyclonal antiserum. The rabbits developed enzyme-linked immunosorbent assay titers Ͼ1:128,000 before exsanguination. The selectivity of the antiserum was validated by the recognition of pc-MAK-V/Hunk-or pHA-MAK-V/Hunk-transfected H9c2 cells by Western blot analysis. Anti-MAK-V/Hunk polyclonal antibodies were affinity-purified.
Immunohistochemistry for MAK-V/Hunk and AT1 receptor within the mouse kidney. Immunohistochemistry was performed as described previously (31) . The kidneys were perfusion-fixed with 4% paraformaldehyde, subsequently embedded in paraffin, and sectioned at 4-m thickness. The sections were dewaxed and rehydrated. Antigen retrieval was performed by microwave heating. The sections were treated for 60 min with 10% normal goat serum in phosphate-buffered saline and blocked for endogenous biotin activity using a AVIDIN/ BIOTIN Blocking kit (Vector Laboratories). For the study of MAK-V/ Hunk, the sections were incubated at 4°C overnight with one of the following diluted in phosphate-buffered saline: 1) MAK-V/Hunk antibody diluted at 1:100, 2) MAK-V/Hunk antibody preabsorbed with a 10-fold excess of the peptide used to generate the antibody, and 3) nonimmune rabbit IgG. For the study of the AT 1 receptor, the sections were incubated at 4°C overnight with either 1) AT 1 receptor antibody (Santa Cruz Biotechnology) diluted at 1:100 or 2) nonimmune rabbit IgG, as described previously (31) . The sections were incubated for 60 min with the biotinylated goat anti-rabbit IgG (Nichirei), blocked for endogenous peroxidase activity by incubation with 0.3% H 2O2 for 20 min, treated for 30 min with the streptavidin and biotinylated peroxidase (DAKO), and then exposed to diaminobenzidine. The sections were counterstained with hematoxylin, dehydrated, and mounted.
Western blot analysis. Western blot analysis was performed essentially as described previously (26, 28, 31) . Briefly, in vitro translated products or cellular extracts were loaded on 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels and transferred to polyvinylidene difluoride membranes (Millipore), which were blocked with phosphate-buffered saline that contained 5% skim milk powder. The membranes were incubated with MAK-V/Hunk antibody diluted at 1:1,000. The membranes were washed and incubated with the goat anti-rabbit IgG conjugated to horseradish peroxidase (Amersham Biosciences) diluted at 1:1,500. Sites of antibody-antigen reaction were visualized by enhanced chemiluminescence (Amersham Biosciences) and placed on film.
Preparation of recombinant adenoviral vectors and gene transfer. Adenoviral vectors were prepared using cDNAs coding for MAK-V/ Hunk (Ad.MAK-V/Hunk) and bacterial ␤-galactosidase (Ad.LacZ) using a commercially available system (Adeno X Expression System, Clontech) as described previously (28) . The virus titer was determined with a plaque assay. Ad.MAK-V/Hunk or Ad.LacZ (5 ϫ 10 9 pfu/ml) was transfected into cells. All experiments were performed 48 h after infection.
In vitro kinase assay. In vitro kinase assay was performed essentially as described previously (6) . Briefly, cellular extracts prepared from the transfected cells by Ad.MAK-V/Hunk or Ad.LacZ were solubilized in 50 mM Tris ⅐ HCl (pH 7.5), 140 mM NaCl, 1 mM CaCl2, 1 mM phenylmethylsulfonyl fluoride, and 1 mg of aprotinin/ml (buffer A) in the presence of 1% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid (CHAPS). The mixture was gently agitated for 30 min at 4°C and incubated at 4°C overnight with MAK-V/Hunk antibody and protein G-Sepharose (Amersham Biosciences). The beads were then washed in buffer A, and in vitro kinase activity of the resulting immunoprecipitates was assayed under final reaction conditions consisting of 20 mM Tris ⅐ HCl (pH 7.5), 5 mM MgCl2, 100 M dATP, 0.5 Ci/l [␥-
32 P]ATP, and 0.15 g/l histone H1 for 45 min at 37°C. The samples were electrophoresed on a sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel and were exposed to the imaging plate of FUJIX BIO-Imaging Analyzer BAS2500 (Fuji Photo Film) as described previously (26, 27) .
Transcriptional c-fos promoter assay. For transcriptional fos promoter assay, the c-fos luciferase reporter genes (p2FTL, 1 g) were transfected into mDCT cells using Lipofectamine 2000 as described previously (12, 28) . The c-fos luciferase reporter gene consists of two copies of the c-fos-regulated enhancer element (Ϫ357 to Ϫ276) containing a serum response element (SRE), the herpes simplex virus thymidine kinase gene promoter, and the luciferase gene (23) . To normalize the transfection efficiency, we employed a dual reporter assay system, in which the pRL-SV40 plasmid (Promega), containing the sea pansy luciferase gene under the control of the SV40 early enhancer/promoter, was cotransfected as an internal control. The transfected cells were incubated with serum-free medium for 48 h. The cells were further incubated in the presence or absence of ANG II (100 nM) or endothelin-1 (10 nM) for 4 h and lysed for luciferase assay.
ELISA of transforming growth factor-␤. ELISA was performed to examine the effect of MAK-V/Hunk on ANG II-mediated transforming growth factor-␤ (TGF-␤) secretion from mDCT cells. mDCT cells were inoculated in the 96-well tray at the concentration 3 ϫ 10 3 /ml, incubated overnight, and infected with Ad.LacZ or Ad.MAK-V/Hunk, and then rested in a serum-free medium for 24 h. The cells were further incubated in the presence or absence of ANG II (100 nM) or aldosterone (1 M) for 36 h. Total TGF-␤ released into the media was measured by an ELISA system (Promega).
Bromodeoxyuridine incorporation assay. The activity of DNA synthesis was evaluated using a bromodeoxyuridine (BrdU) Labeling and detection kit (Boehringer Mannheim). The mDCT cells were inoculated in the 96-well tray at the concentration 3.2 ϫ 10 3 /ml, incubated overnight, and infected with Ad.LacZ or Ad.MAK-V/Hunk, and further incubated in the presence or absence of ANG II (100 nM) or endothelin-1 (10 nM) for 48 h. BrdU labeling was performed during the last 4 h. The incorporated BrdU in place of thymidine into the DNA of proliferating cells was assayed by incubation with an anti-BrdU antibody, detected by a subsequent enzyme reaction and quantified spectrophotometrically at 405 nm. The statistical analysis was performed using the unpaired t-test. A P value of Ͻ0.05 was considered to be statistically significant.
RNA interference. The RNA interference experiment was performed essentially as described previously (12) . Briefly, small interference RNA (siRNA) with 25 nucleotides was synthesized from Invitrogen Technology (Stealth RNAi). To knockdown the endogenous MAK-V/Hunk expression, the sense oligonucleotide is 5Ј-GAG ACU UGA AGA UAG AGA AUU UGC U-3Ј, and the antisense oligonucleotide is 5Ј-AGC AAA UUC UCU AUC UUC AAG UCU C-3Ј. As a negative control, the sense oligonucleotide 5Ј-GAG AGU UUA GAG AGA UUA AUC AGC U-3Ј, and the antisense oligonucleotide 5Ј-AGC UGA UUA AUC UCU CUA AAC UCU C-3Ј were synthesized. The annealed double-strand siRNA (20 nM) was introduced into mouse distal convoluted tubule (mDCT) cells with the help of Lipofectamine 2000 (Invitrogen). Forty-eight hours after transfection nuclear extracts were prepared and subjected to Western blot analysis.
Statistical analysis. Values are expressed as means Ϯ SE in the text and figures. The data were analyzed using ANOVA. If a statistically significant effect was found, a post hoc analysis was performed to detect the difference between the groups. Values of P Ͻ 0.05 were considered statistically significant.
RESULTS

Expression of MAK-V/Hunk mRNA in mouse tissues.
We previously isolated protein kinases from early differential stages of mouse ES cells by using degenerative oligonucleotide primers specific to the consensus sequences of a great number of protein kinases (7) . PCR products from each cDNA source were subcloned individually and screened by DNA sequencing. One of these encompassed the putative kinase domain of a serine/threonine kinase MAK-V/Hunk corresponding to amino acid residues 182-249 (6, 18), which we named the MAK-V/Hunk probe. We first examined the endogenous expression of MAK-V/Hunk mRNA in adult C57BL/6J mouse tissues. The result of Northern blot analysis using the MAK-V/Hunk probe showed that MAK-V/Hunk mRNA was expressed much more abundantly in the kidney, brain, and lung, and only faintly in adipose tissue (Fig. 1A) . This result is essentially consistent with a previous report of Gardner et al. (6) describing a tissue distribution of MAK-V/Hunk in FVB mouse. RT-PCR analysis also revealed endogenous expression of MAK-V/Hunk mRNA in the kidney cortex as well as the medulla (Fig. 1B) .
Isolation of cDNA clones encoding MAK-V/Hunk. To obtain the cDNA clone covering the entire MAK-V/Hunk protein coding region, we performed plaque-lifting hybridization screening of a mouse kidney cDNA library (CLONTECH Laboratories) using a [
32 P]dCTP-labeled random-primed MAK-V/Hunk probe (TaKaRa Biomedicals). The longest clone was completely DNA sequenced to ensure that no nucleotide substitutions had occurred (data not shown), and we successfully obtained a cDNA covering the entire MAK-V/ Hunk protein coding region.
The results of an in vitro transcription and translation reaction performed in the presence of [ 35 S]methionine showed a prominent band of 80 kDa, which was consistent with the predicted molecular weight (79.6) of MAK-V/Hunk, thereby supporting that the MAK-V/Hunk cDNA cloned in this study covered the entire MAK-V/Hunk protein coding region (Fig.  1C) (6) .
Production and validation of the specificity of the antibody for MAK-V/Hunk. We next generated a rabbit anti-MAK-V/ Hunk polyclonal antibody. Western blot analysis of HA epitope-tagged MAK-V/Hunk-transfected H9c2 cells revealed that the MAK-V/Hunk antibody as well as the anti-HA antibody recognized the apparent molecular mass of the major bands ϳ80 kDa, which was consistent with the results of in vitro transcription and translation reaction (Fig. 1D, lanes 2  and 3) . The result also revealed the presence of two bands of ϳ80 kDa and suggested that this doublet represents a product of posttranslational modification. These bands were not observed when empty vector pHA-transfected H9c2 cells were used instead of MAK-V/Hunk-transfected cells or when the MAK-V/Hunk antibody was preabsorbed with a 10-fold excess of the peptide used to generate the antibody (Fig. 1D, lanes 1  and 4) . These data indicate that the MAK-V/Hunk antibody is able to recognize the MAK-V/Hunk protein specifically.
Immunohistochemistry for MAK-V/Hunk protein in the mouse adult kidney. Since the result of Northern blot analysis revealed that the MAK-V/Hunk gene was highly expressed in the kidney, we determined the distribution of the MAK-V/ Hunk protein in kidney sections from the normal adult mouse by immunohistochemistry. We found the protein translational sites of MAK-V/Hunk to be localized to the cortex and outer medulla of the kidney, but not to the region of the inner medulla and papilla ( Fig. 2A) . To identify the definite sites of MAK-V/Hunk immunostaining, consecutive sections were stained for MAK-V/Hunk and markers specific for the tubular segments. We used a polyclonal antibody against TammHorsfall protein that is specifically expressed in the thick ascending limbs (TAL) and found that MAK-V/Hunk immunostaining was detected in the TAL but not in the collecting ducts (Fig. 2B, MAK-V/Hunk; Fig. 2C , Tamm-Horsfall pro-tein). We also used a monoclonal antibody against calbindin-D, a calcium-binding protein expressed primarily in the DCTs and the connecting tubules (CNT) (19, 32) , and the immunoreactivity of the MAK-V/Hunk protein was observed specifically in the DCT and CNT (Fig. 2D , MAK-V/Hunk; Fig. 2E, calbindin-D) .
Significant staining was not found in the glomeruli, the proximal tubules, the collecting ducts, or in the vasculature, including the arcuate artery, interlobular arteries, and arterioles (data not shown). No immunoreactivity of the MAK-V/Hunk protein was found in the negative control sections that were consecutive sections incubated with preabsorption of the anti-MAK-V/Hunk antibody along with the competing antigenic peptide and incubated with nonimmune rabbit IgG (data not shown). These results demonstrated a specific expression of MAK-V/Hunk in the TAL, DCT, and CNT in the adult mouse kidney.
Immunohistochemistry for MAK-V/Hunk protein in the mouse embryonic kidney. Since a previous study using in situ hybridization technique detected MAK-V/Hunk mRNA in the embryonic kidney (E13.5 and E18.5) (6), we examined whether the MAK-V/Hunk protein was expressed in the developing kidney. We determined the distribution of MAK-V/ Hunk protein in kidney sections from the normal mouse embryo (E15.5) by immunohistochemistry. A high level of MAK-V/Hunk immunostaining was detected specifically in the distal tubules, which was confirmed by a serial section stained with antiTamm-Horsfall antibody (Fig. 3A , MAK-V/Hunk; Fig. 3B , Tamm-Horsfall protein).
Effect of dietary salt depletion on mRNA expression of MAK-V/Hunk in the mouse kidney. The above results demonstrated the restricted expression sites of MAK-V/Hunk in distal tubules in the kidney. Because tubular salt reabsorption is a major functional role of renal distal tubules, we investigated the effect of dietary salt depletion on MAK-V/Hunk expression. Mice were fed a low-or normal-salt diet for 2 wk. The mean body weight of the mice fed a low-salt diet (25.7 Ϯ 1.3 g, n ϭ 4) was not significantly different from that of the mice fed a normal-salt diet (24.6 Ϯ 0.7 g, n ϭ 4) at the end of the experiment. Systolic blood pressure was not significantly changed by a low-salt diet (129.3 Ϯ 9.6 mmHg, n ϭ 4) compared with a normal-salt diet (116.0 Ϯ 6.2 mmHg, n ϭ 4). Renal expression of MAK-V/Hunk and AT 1 receptor mRNA in the mice consuming a low-or a normal-salt diet was determined by real-time quantitative PCR analysis. Salt depletion led to a 32% increase in the renal expression of the MAK-V/ Hunk mRNA compared with a normal-salt diet (Fig. 4A) , while the renal expression of AT 1 receptor mRNA was decreased by 27% by a low-salt diet (Fig. 4B) .
Endogenous expression of MAK-V/Hunk in mouse renal distal tubular cells.
Because the results of in vivo study demonstrated that renal MAK-V/Hunk is expressed specifically in the distal tubules in the kidney, we used mDCT cells for in vitro study (4) . These cells have been shown to have the phenotype of a polarized tight junction epithelium with morphological and functional features retained from the parental distal convoluted tubule cells (9, 10) . The mDCT cells express the endogenous MAK-V/Hunk mRNA as detected by RT-PCR (Fig. 5A) . Western blot analysis using the anti-MAK-V/Hunk antibody also recognized the endogenous MAK-V/Hunk protein of ϳ80 kDa in mDCT cells (Fig. 5B ). These results demonstrate that the MAK-V/Hunk protein is endogenously expressed in mDCT cells. tivity was significantly greater in immunoprecipitates prepared from Ad.MAK-V/Hunk-infected mDCT cells compared with Ad.LacZ-infected mDCT cells (Fig. 6B) . These findings demonstrated that the MAK-V/Hunk cDNA clone isolated encodes a functional protein kinase and that the kinase activity is substantially increased by overexpression of MAK-V/Hunk.
Effect of adenoviral transfer of recombinant MAK-V/Hunk
MAK-V/Hunk belongs to a new branch of the SNF1 family (1). The SNF1 family of kinases has been implicated in the regulation of intracellular mediators of responses related to cell growth and differentiation. ANG II is another well-known activator of these signaling pathways, and ANG II is capable of inducing the synthesis of the profibrotic cytokine TGF-␤ in renal tubules, associated with subsequent alterations in cell growth and matrix production (21, 35) . Thus, to investigate a possible role of MAK-V/Hunk in the functional modulation of distal tubular cells, we examined the effects of MAK-V/Hunk on the downstream effectors of the AT 1 receptor-signaling pathway in mDCT cells by performing adenoviral transfer of recombinant MAK-V/Hunk. We performed c-fos transcriptional assay, ELISA of TGF-␤, and BrdU incorporation assay.
In mDCT cells infected by Ad.LacZ, treatment with ANG II (100 nM) induced the c-fos reporter gene by 1.9-fold (Fig. 6C) . In contrast, pretreatment with an AT 1 receptor-specific antagonist telmisartan (1 M), but not an AT 2 receptor-specific antagonist PD123319 (10 M), completely inhibited ANG II-mediated activation of c-fos reporter gene expression. Interestingly, overexpression of MAK-V/Hunk also significantly decreased the ANG II-induced activation of c-fos gene tran- scription but did not affect the endothelin-1-mediated increase in c-fos gene transcription (Fig. 6C) . Similarly, ANG II (100 nM) treatment of mDCT cells infected with Ad.LacZ showed an increase in the secretion of TGF-␤ protein into the medium, which was blocked by pretreatment with telmisartan (1 M) but not PD123319 (10 M; Fig. 6D ). mDCT cells infected with Ad.MAK-V/Hunk exhibited a significant inhibition of the ANG II-induced enhancement of TGF-␤ secretion into the medium, while the aldosterone-mediated increase in TGF-␤ secretion was not blocked by overexpression of MAK-V/Hunk (Fig. 6D) . Furthermore, treatment with ANG II (100 nM) significantly augmented BrdU incorporation into mDCT cells infected with Ad.LacZ (Fig. 6E) . Although the baseline BrdU incorporation was not affected by infection with Ad.MAK-V/ Hunk, the ANG II-mediated activation of BrdU incorporation was siginificantly suppressed by overexpression of MAK-V/ Hunk (Fig. 6E) . Again, the endothelin-1-induced activation of BrdU incorporation was not affected at all by overexpression of MAK-V/Hunk.
Effects of the suppression of endogenous MAK-V/Hunk expression on c-fos promoter activity in renal distal tubular cells.
To further investigate the putative functional role of MAK-V/ Hunk in renal distal tubular cells, we examined the effect of RNA interference MAK-V/Hunk knockdown on the regulation of c-fos promoter activity in mDCT cells. Transfection of MAK-V/Hunk siRNA significantly decreased the MAK-V/ Hunk protein levels as revealed by the result of Western blot analysis, whereas the control siRNA had no effect (Fig. 7A) .
Furthermore, knockdown of endogenous MAK-V/Hunk expression sensitized the stimulatory effect of ANG II (100 nM) on c-fos gene transcription (Fig. 7B) . These results indicate that MAK-V/Hunk is involved in the suppression of the ANG II-induced proliferative activity of the renal distal tubular cells.
Colocalization of ATRAP with AT 1 receptor in the mouse adult kidney. Finally, to examine a possible colocalization of MAK-V/Hunk and AT 1 receptor in the kidney, immunohistochemistry using the MAK-V/Hunk antibody and the AT 1 receptor antibody within kidney sections from normal adult mouse was performed. In the consecutive sections stained for MAK-V/Hunk and AT 1 receptor in the renal cortex, MAK-V/ Hunk-immunopositive tubules, which were mainly DCT, expressed the AT 1 receptor, and the immunoreactivity of both MAK-V/Hunk and AT 1 receptor was intense on the basal side of the distal tubules (Fig. 8) .
DISCUSSION
A novel mammalian SNF1-related protein kinase, MAK-V/ Hunk, was originally cloned by Gardner et al. and Korobko et al. (2, 5, 6, 18) as a kinase rich in the mouse mammary gland with regulated expression during pregnancy-induced changes in the mammary gland. Gardner et al. (5, 6) reported that MAK-V/ Hunk is expressed in subsets of cells within several tissues including the brain, lung, ovary, thymus, kidney, duodenum, and uterus in addition to the breast, and showed that MAK-V/ Hunk expression is developmentally regulated and tissue specific.
In the present study, we focused on the characterization of renal MAK-V/Hunk in vivo and in vitro. We identified the fact that MAK-V/Hunk is highly expressed in the kidney and its expression level is increased by salt restriction. In the kidney MAK-V/Hunk expression is restricted to the distal tubules, and specifically, the endogenous expression of MAK-V/Hunk was demonstrated in mDCT cells derived from mouse distal renal tubular cells (4) . The mDCT cells have been shown to have the phenotype of a polarized tight junction epithelium with morphologic and functional features retained from the parental distal convoluted tubule cells (9, 10) . Moreover, the results of functional assays using mDCT cells infected by the adenoviral MAK-V/Hunk expression vector and transcriptional c-fos promoter assay using mDCT cells transiently transfected with MAK-V/Hunk siRNA indicate that MAK-V/Hunk plays a role in the regulation of cellular proliferative activity in response to ANG II, a potent stimulator of renal remodeling and fibrotic signaling (34, 36) .
There has been no previous report that examines the spatial and temporal distribution of MAK-V/Hunk in the kidney in detail. By immunohistochemistry, we demonstrated that the MAK-V/Hunk protein was specifically expressed in the TAL, DCT, and CNT but not in other nephron segments, the glomerulus, or vessels of the kidney. This is the first report to demonstrate the restricted distribution of MAK-V/Hunk protein in the distal nephron segments in embryonic kidney as well as adult kidney. This finding is essentially consistent with a previous study performed by in situ hybridization, which showed that the expression of MAK-V/Hunk mRNA is generally restricted to a subset of cells within particular compartments (6) . Furthermore, the finding that the MAK-V/Hunk protein is highly and specifically expressed in the distal tubules of the embryonic kidney suggests that this kinase may have a role in the development of the renal distal tubules. Since the consecutive renal sections were stained for MAK-V/Hunk and markers of nephron segments (Tamm-Horsfall protein and calbindin-D) to examine the nephron segment-specific expression of MAK-V/Hunk, limitations of the present study include the lack of immunofluorescent colocalization analysis with double staining of MAK-V/Hunk and these specific markers using the multiple fluorolabeling method and confocal laser microscopy.
The restricted expression pattern of the MAK-V/Hunk protein in the kidney might be explained by the mechanism of transcriptional regulation. For example, the promoter regions of ksp-cadherin and thiazide-sensitive Na-Cl cotransporter contain consensus binding motifs for activator protein-2 (AP-2) and DCT-specific transcription factor hepatocyte nuclear factor-3/folk head homolog-3 (HFH-3) that confer specific expression in renal distal tubular epithelial cells (14, 29, 33) . Since we have found that the promoter region (from Ϫ1.0 kb to ϩ1 of the transcriptional start site) of MAK-V/Hunk also contains several putative binding sites for AP-2 and HFH-3 (data not shown), it is possible that these sites are involved in the specific expression of MAK-V/Hunk in the renal distal tubular cells.
Accumulated evidence demonstrated that the distal nephron including TAL and DCT is important for the regulation of the handling of sodium (16) . In addition, a previous study showed that the AMP-activated protein kinase (AMPK), another SNF-1 family kinase, is also expressed in the renal distal tubules and that dietary salt intake regulates the activity of AMPK in the kidney (3) . In this study, we found that the renal expression of MAK-V/Hunk is increased by dietary salt restriction. Dietary salt depletion is known to increase the components of the renin-angiotensin system in the kidney, to activate the circulating renin-angiotensin system (15, 17) , and to decrease the expression of renal AT 1 receptor mRNA (24, 25) . The result from the present study indicates that MAK-V/ Hunk and the AT 1 receptor are regulated in opposite directions by the conditions that alter the activity of the renin-angiotensin system in vivo and suggests that tubular Na ϩ and/or Cl Further molecular screens for both MAK-V/Hunk and AT 1 receptor will reveal the existence of additional partners for these molecules that may act cooperatively or independently both in time and in a specific cellular location in the kidney. These questions are interesting, and our laboratory is actively characterizing these interactions.
MAK-V/Hunk belongs to a new branch of the SNF1 family (1). The SNF1 family of kinases has been implicated in the regulation of developmental processes including cell cycle control, establishment of cell polarity, and differentiation. In the current study, gain-of-function and loss-of-function approaches demonstrated that MAK-V/Hunk negatively regulates cellular proliferative activity in distal tubular cells. Overexpression of MAK-V/Hunk by adenoviral gene transfer in mDCT cells blocked the ANG II-induced increases in c-fos transcriptional activity, TGF-␤ production, and BrdU incorporation, but did not affect the stimulatory effects by endohtelin-1 or aldosterone. Theses results indicate that the MAK-V/Hunk overexpression specifically suppressed AT 1 receptor signaling in distal tubular cells. A previous study showed that the overexpression of MAK-V/Hunk in the mammary epithelium of MMTV-MAK-V/Hunk transgenic mice results in decreased proliferation of alveolar epithelial cells during pregnancy (5), consistently with our results. Conversely, the MAK-V/Hunk knockdown by siRNA increased the stimulatory effect of ANG II on the c-fos transcriptional activity.
The precise functions of MAK-V/Hunk in the renal distal tubular cells remain to be determined, but the results do imply that MAK-V/Hunk could well have a role in both the developmental and physiological functioning of the distal nephron via a modulation of cellular proliferative activity. Further studies will be needed to elucidate the molecular mechanism of MAK-V/Hunk-mediated inhibition of ANG II signaling in renal pathophysiology, and these will be undertaken in due course. In conclusion, this study demonstrates the abundant and specific expression of MAK-V/Hunk and distribution in the kidney. MAK-V/Hunk is specifically and highly expressed in the distal tubules of the embryonic and adult kidney, and this is the first report characterizing the cellular function of MAK-V/ Hunk in renal tubular cells.
